Ignite Creation Date:
2024-05-06 @ 12:33 PM
Last Modification Date:
2024-10-26 @ 1:01 PM
Study NCT ID:
NCT03795428
Status:
TERMINATED
Last Update Posted:
2022-02-22
First Post:
2018-12-18
Brief Title:
Long-Term Open Label Extension Study of Pemziviptadil PB1046 in PAH Subjects Following Completion of Study PB1046-PT-CL-0004
Sponsor:
PhaseBio Pharmaceuticals Inc
Organization:
PhaseBio Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-10
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-11
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-18
First Submit QC Date:
January 4 2019
Study First Post Date:
2019-01-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-04
Last Update Post Date:
2022-02-22
Last Update Post Date Type:
ACTUAL